[{"Assets_0_Q3_USD":"64662000000.0","CIK":"882095","CommonStockDividendsPerShareDeclared_1_Q3_USD":"0.52","CommonStockDividendsPerShareDeclared_3_Q3_USD":"1.56","CommonStockSharesIssued_0_Q3_shares":"1307000000.0","CommonStockSharesOutstanding_0_Q3_shares":"1307000000.0","Country":"United States","EarningsPerShareBasic_1_Q3_USD":"2.08","EarningsPerShareBasic_3_Q3_USD":"6.5","EarningsPerShareDiluted_1_Q3_USD":"2.06","EarningsPerShareDiluted_3_Q3_USD":"6.44","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","Market Cap":"78838305412.0","MinorityInterest_0_Q3_USD":"409000000.0","NetCashProvidedByUsedInOperatingActivitiesConverted_3_Q3_USD":"9145000000.0","NetIncomeLoss_1_Q3_USD":"2718000000.0","NetIncomeLoss_3_Q3_USD":"8493000000.0","OfficialName":"Gilead Sciences Inc. Common Stock","PaymentsOfDividends_3_Q3_USD":"2049000000.0","ProfitLoss_1_Q3_USD":"2712000000.0","ProfitLoss_3_Q3_USD":"8480000000.0","RevenuesConverted_1_Q3_USD":"6512000000.0","RevenuesConverted_3_Q3_USD":"20158000000.0","SP500":"SP500","Sector":"Health Care","StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":"25254000000.0","StockholdersEquity_0_Q3_USD":"24845000000.0","Ticker":"GILD","WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":"1319000000.0","WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":"1319000000.0","WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":"1306000000.0","WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":"1307000000.0","filed":"20171107","footnote":null,"form":"10-Q","fp":"Q3","fy":"2017.0","name":"GILEAD SCIENCES INC","period":"20170930","qtrs":"0","uom":"USD"}]